GSK plc

GSK

GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical company headquartered in London, England.

About GSK plc

Share price for GSK plc

LON: GSK Dividends

Historical Data

Latest GSK plc News

GSK Plc

GSK Plc names Luke Miels as CEO Designate, effective January 2026

GSK has announced the appointment of Luke Miels as CEO Designate, with full responsibilities and a Board position from 1...
GSK

GSK’s Gepotidacin receives US FDA Priority Review for gonorrhoea treatment

GSK has announced that the US FDA has accepted for priority review a supplemental New Drug Application for gepotidacin as...
GSK plc

GSK to receive $370m settlement and royalties from mRNA patent agreement

GSK will receive a $370 million upfront payment, plus 1% royalties on US sales of certain mRNA vaccines by BioNTech...
GSK plc

GSK raises 2025 guidance after strong Q2 performance

GSK reported Q2 2025 turnover of £8.0bn, up 6% CER, with strong growth in Specialty Medicines (+15%) and Vaccines (+9%)....
GSK

GSK and Hengrui Pharma to develop up to 12 new medicine programmes

GSK plc has entered agreements with Hengrui Pharma to develop up to 12 innovative medicines, including an exclusive worldwide licence...
GSK plc

GSK’s Arexvy FDA review accepted for adults 18-49 at increased risk

The US FDA has accepted GSK’s application to extend Arexvy to adults aged 18-49 at increased risk of severe RSV...

Share this page

Twitter
LinkedIn
Facebook
Email
WhatsApp

Data policy – All information should be used for indicative purposes only. You should independently check data before making any investment decision and or seek professional advice. DirectorsTalk cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.